VanEck Associates’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24
| Closed | -$2K | – | 1420 |
|
|
2024
Q3 | $2K | Sell |
24
-1
| -4% | -$83 | ﹤0.01% | 1370 |
|
|
2024
Q2 | $2K | Sell |
25
-5
| -17% | -$400 | ﹤0.01% | 1366 |
|
|
2024
Q1 | $3K | Sell |
30
-34
| -53% | -$3.4K | ﹤0.01% | 1355 |
|
|
2023
Q4 | $5K | Hold |
64
| – | – | ﹤0.01% | 1365 |
|
|
2023
Q3 | $5K | Hold |
64
| – | – | ﹤0.01% | 1374 |
|
|
2023
Q2 | $5K | Hold |
64
| – | – | ﹤0.01% | 1380 |
|
|
2023
Q1 | $5K | Buy |
64
+13
| +25% | +$1.02K | ﹤0.01% | 1386 |
|
|
2022
Q4 | $4K | Hold |
51
| – | – | ﹤0.01% | 1404 |
|
|
2022
Q3 | $3K | Hold |
51
| – | – | ﹤0.01% | 1369 |
|
|
2022
Q2 | $4K | Hold |
51
| – | – | ﹤0.01% | 1341 |
|
|
2022
Q1 | $4K | Hold |
51
| – | – | ﹤0.01% | 1337 |
|
|
2021
Q4 | $4K | Buy |
+51
| New | +$4K | ﹤0.01% | 1346 |
|